| 14.97 Data as of May 17 |  -0.14 / -0.93%Today’s Change | 8.64 Today|||52-Week Range 16.80 | +65.41% Year-to-Date |
| 3 Biotech Stocks Spiking With Big Volume May 13 / TheStreet.com | Wider-than-Expected Loss at Optimer - Analyst Blog May 10 / Zacks.com |
| Optimer Pharmaceuticals Misses on the Top and Bottom Lines May 10 / MotleyFool.com |
| Previous close | 15.11 |
| Today’s open | 15.11 |
| Day’s range | 14.74 - 15.48 |
| Volume | 1,341,138 |
| Average volume (3 months) | 1,010,526 |
| Market cap | $729.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -558.82% |
| Earnings growth (this year) | -186.25% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -29.97% |
| P/E ratio | NM |
| Price/Sales | 4.22 |
| Price/Book | 5.47 |
| Today’s change | Today’s % change | |
|---|---|---|
| AUXLAuxilium Pharmaceuti... | -0.04 | -0.27% |
| CBPOChina Biologic Produ... | +0.34 | +1.30% |
| ACHNAchillion Pharmaceut... | +0.21 | +2.78% |
| ARRYArray Biopharma Inc | +0.20 | +3.51% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $101.5M |
| Annual profit (last year) | -$37.0M |
| Net profit margin | -36.43% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Henry A. McKinnell, Jr., PhD |
Senior Vice President- Operations Robert Michael Savel, II |
Corporate headquarters Jersey City, New Jersey |
.
